Illumina, Inc. (FRA:ILU)
Germany
· Delayed Price · Currency is EUR 72.68
-0.24 (-0.33%)
At close: May 13, 2025, 10:00 PM CET
Illumina Revenue
Illumina had revenue of $1.04B USD in the quarter ending March 30, 2025, a decrease of -3.25%. This brings the company's revenue in the last twelve months to $4.34B, down -3.47% year-over-year. In the year 2024, Illumina had annual revenue of $4.37B, down -2.93%.
Revenue (ttm)
$4.34B
Revenue Growth
-3.47%
P/S Ratio
2.84
Revenue / Employee
$480.29K
Employees
9,030
Market Cap
11.38B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 4.37B | -132.00M | -2.93% |
| Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
| Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
| Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
| Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
| Dec 29, 2019 | Pro | Pro | Pro |
| Dec 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jan 1, 2017 | Pro | Pro | Pro |
| Jan 3, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 76.54B |
| Deutsche Telekom AG | 118.43B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 10.48B |
| Siemens Energy AG | 37.44B |
| Merck KGaA | 21.16B |
Illumina News
- 4 days ago - Illumina outlines $4.18B to $4.26B guidance for 2025 amid China headwinds and strategic cost reductions - Seeking Alpha
- 4 days ago - Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Illumina down 3% as lowered 2025 EPS guidance overshadows Q1 top-line beat - Seeking Alpha
- 12 days ago - Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development - PRNewsWire
- 22 days ago - Rep. Thomas Kean Has Bought Up to $45K Worth Of Illumina Stock: Here's What You Should Know - Benzinga
- 25 days ago - Target Validation for Genetic Targets Innovation Research Report 2025: 14,172 Deals Totaling $11.4 Billion - BGI biotech and illumina are Among the Leaders with Strong Portfolios - GlobeNewsWire
- 4 weeks ago - Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation - PRNewsWire
- 4 weeks ago - Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025 - PRNewsWire